CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $88.61, but opened at $85.95. CochLear shares last traded at $85.95, with a volume of 306 shares.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on CHEOY. Zacks Research upgraded shares of CochLear to a “hold” rating in a research report on Monday, August 11th. Canaccord Genuity Group upgraded shares of CochLear from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Finally, Citigroup downgraded shares of CochLear to a “neutral” rating in a research report on Thursday, September 18th. Two equities research analysts have rated the stock with a Strong Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Stock Report on CochLear
CochLear Trading Down 1.2%
CochLear Announces Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, October 28th. Investors of record on Monday, September 22nd were issued a dividend of $0.1045 per share. The ex-dividend date of this dividend was Friday, September 19th. This represents a yield of 122.0%.
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Lowe’s Stock Price Signals a Buying Opportunity After Q3 Release
- Most active stocks: Dollar volume vs share volume
- NVIDIA Just Proved the AI Boom Is Bigger Than Anyone Thought
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Why Target Stock May Keep Falling Despite a 5% Dividend Yield
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
